Brief: Caredx Completes Acquisition Of Naveris, Extending Leadership Into High-Growth Specialty Oncology
01/07/2026 21:10
BRIEF-Caredx Completes Acquisition Of Naveris, Extending Leadership Into High-Growth Specialty Oncology July 1 (Reuters) - CareDx Inc CDNA.O:
CAREDX COMPLETES ACQUISITION OF NAVERIS, EXTENDING LEADERSHIP INTO HIGH-GROWTH SPECIALTY ONCOLOGY
Source text: ID:nBw4rSlYja
Further company coverage: CDNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareDx
See all newsBrief: Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 revenue beats estimates; outlook lifted
Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23